Sale

Psoriasis Treatment Market

Global Psoriasis Treatment Market Share, Trends, Forecast: By Diagnosis Method: Blood Tests, Skin Prick Test, Others; By Treatment Type; By Type; By Therapy Type; By Route of Administration; By Drug Type; By Population Type; By Treatment Channel; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Psoriasis Treatment Market Outlook

The global psoriasis treatment market value was USD 28.54 billion in 2023, driven by the increasing prevalence of psoriasis across the globe. The market size is anticipated to grow at a CAGR of 9.2% during the forecast period of 2024-2032 to achieve a value of USD 63.18 billion by 2032.

 

Global Psoriasis Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The Increasing Prevalence of Psoriasis Disease is Augmenting the Market Growth of Psoriasis Treatment

The global market for psoriasis treatment is being driven by increasing incidences of psoriasis due to certain genetic or environmental factors, thereby augmenting the demand for effective treatment and hence stimulating the growth of the market.

According to the World Health Organisation, the reported prevalence of psoriasis in countries range from 0.09% to 11.4%, making it a serious global problem. A combination of topical and systematic therapies to reduce the effects of psoriasis is a lifelong treatment aimed at remission, has been driving the growth of the market. Thus, robust investments towards the development of advanced treatment methods to control the spread of psoriasis disease are aiding the market growth.

 

Psoriasis Treatment: Market Segmentation

Psoriasis refers to a common inflammatory condition in which skin cells build up and form scales and itchy, dry patches. Treatment such as topical ointments, light therapy, and medication aims to remove scales and stop the robust growth of skin cells.

 

Global Psoriasis Treatment Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of drug class, the market can be divided into:

  • TNF Inhibitors 
  • Interleukins
  • Others

Based on type, the market can be categorised into:

  • Plaque Psoriasis
  • Psoriatic Arthritis
  • Others

The market, based on route of administration, can be segmented into:

  • Oral
  • Parenteral 
  • Topical

On the basis of distribution channel, the market can be classified into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The EMR report looks into the regional markets of psoriasis treatment like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

 

Global Psoriasis Treatment Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Robust Research and Development (R&D) for the Development of Effective Treatments to Propel the Market Growth

The growth in the global market for psoriasis treatment is expected to be determined by the rising awareness regarding the negative impact of the disease. Since the exact reason for the psoriasis disease is unknown, robust research and development (R&D) about the cause, potential effects, and effective treatments is expected to have a significant influence over the growth of the market. In addition to this, favourable government measures such as reimbursement schemes, subsidised treatments, and other thoughtful measures are also expected to boost the market growth. Moreover, the market is further projected to grow due to the presence of an extensive distribution channel, including retail and hospital pharmacies and online channels, which aid in the easy availability of the medication. Hence, these factors are anticipated to bolster the overall market growth of psoriasis treatment.

 

Key Industry Players in the Global Psoriasis Treatment Market

The report presents a detailed analysis of the following key players in the global psoriasis treatment market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:

  • AbbVie Inc.
  • Novartis AG 
  • Johnson and Johnson Services, Inc.
  • Pfizer Inc. 
  • Merc and Co., Inc. 
  • Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Diagnosis Method
  • Treatment Type
  • Type
  • Therapy Type
  • Route of Administration
  • Drug Type
  • Population Type
  • Treatment Channel
  • End User
  • Distribution Channel
  • Region
Breakup by Diagnosis Method
  • Blood Tests
  • Skin Prick Test
  • Patch Test
  • Biopsy
  • Others
Breakup by Treatment Type
  • Biologics Drugs
  • Systemic Drugs
  • Phototherapy
  • Topical Drugs
  • Others
Breakup by Type
  • Plaque Psoriasis
  • Psoriatic Arthritis
  • Others
Breakup by Therapy Type
  • Monotherapy
  • Combination Therapy
Breakup by Route of Administration
  • Oral
  • Parentals
  • Topicals
  • Others
Breakup by Drug Type
  • Over the Counter
  • Prescription
Breakup by Population Type
  • Childs
  • Adults
  • Geriatrics
Breakup by Treatment Channel
  • Public
  • Private
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Abbvie Inc.
  • Novartis AG
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH.
  • Merck & Co Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • AstraZeneca
  • Ampio Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Novartis International AG
  • Sun Pharmaceuticals Industries Ltd.
  • Stiefel Laboratories
  • UCB S.A.
  • LEO Pharma
  • Cipla Inc.
  • Rowan Bioceuticals
  • Glenmark Pharmaceuticals
  • Win-Medicare Pvt. Ltd.
  • Sanofi S.A.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Psoriasis Disease Overview 

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Psoriasis Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Psoriasis Epidemiology (2016-2031)
    5.3    Europe Psoriasis Epidemiology (2016-2031)
    5.4    Asia-Pacific Psoriasis Epidemiology (2016-2031)
    5.5    Latin America Psoriasis Epidemiology (2016-2031)
    5.6    Middle East & Africa Psoriasis Epidemiology (2016-2031)
6    Global Psoriasis Treatment Market Overview 
    6.1    Global Psoriasis Treatment Market Historical Value (2017-2023) 
    6.2    Global Psoriasis Treatment Market Forecast Value (2024-2032)
7    Global Psoriasis Treatment Market Landscape
    7.1    Psoriasis Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Psoriasis Treatment: Product Landscape
        7.2.1    Analysis by Treatment Type
        7.2.2    Analysis by Psoriasis Type
        7.2.3    Analysis by Therapy Type
        7.2.4    Analysis by Distribution Channel
        7.2.5    Analysis by End User
8    Psoriasis Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Psoriasis Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Psoriasis Treatment Market Segmentation
    11.1    Global Psoriasis Treatment Market by Diagnosis Method 
        11.1.1    Market Overview
        11.1.2    Blood Tests
        11.1.3    Skin Prick Test
        11.1.4    Patch Test
        11.1.5    Biopsy 
        11.1.6    Others
    11.2    Global Psoriasis Treatment Market by Treatment Type
        11.2.1    Market Overview
        11.2.2    Biologics Drugs
            11.2.2.1    Apremilast
            11.2.2.2    Atanercept
            11.2.2.3    Infliximab
            11.2.2.4    Adalimumab
            11.2.2.5    Ustekinumab
            11.2.2.6    Secukinumab
            11.2.2.7    Ixekizumab
            11.2.2.8    Guselkumab
            11.2.2.9    Tildrakizumab
            11.2.2.10    Certolizumab
            11.2.2.11    Others
        11.2.3     Systemic Drugs
            11.2.3.1    Methotrexate
            11.2.3.2    Soriatane
            11.2.3.3    Otezla
            11.2.3.4    Sotyktu
            11.2.3.5    Cyclosporin
            11.2.3.6    Others
        11.2.4    Phototherapy
            11.2.4.1    Ultraviolet B (UVB)
        11.2.5    Topical Drugs
            11.2.5.1    Calcipotriene
            11.2.5.2    Tazarotene
            11.2.5.3    Calcineurin inhibitors
            11.2.5.4    Roflumilast
            11.2.5.5    Salicylic acid
            11.2.5.6    Others
        11.2.6    Others
    11.3    Global Psoriasis Treatment Market by Type
        11.3.1    Market Overview
        11.3.2    Plaque Psoriasis
        11.3.3    Psoriatic Arthritis
        11.3.4    Others
    11.4    Global Psoriasis Treatment Market by Therapy Type
        11.4.1    Market Overview
        11.4.2    Monotherapy
        11.4.3    Combination Therapy
    11.5    Global Psoriasis Treatment Market by Route of Administration
        11.5.1    Market Overview
        11.5.2    Oral
            11.5.2.1    Tablets
            11.5.2.2    Capsules
        11.5.3    Parentals
            11.5.3.1    Intravenous
            11.5.3.2    Intramuscular
        11.5.4    Topicals
        11.5.5    Others
    11.6    Global Psoriasis Treatment Market by Drug Type
        11.6.1    Market Overview
        11.6.2    Over the Counter
        11.6.3    Prescription
            11.6.3.1    Branded
            11.6.3.2    Generics
    11.7    Global Psoriasis Treatment Market by Population Type
        11.7.1    Market Overview
        11.7.2    Childs
        11.7.3    Adults
            11.7.3.1    Male 
            11.7.3.2    Female
        11.7.4    Geriatrics
            11.7.4.1    Male 
            11.7.4.2    Female
    11.8    Global Psoriasis Treatment Market by Treatment Channel
        11.8.1    Market Overview
        11.8.2    Public
        11.8.3    Private
    11.9    Global Psoriasis Treatment Market by End User
        11.9.1    Market Overview
        11.9.2    Hospitals
        11.9.3    Specialty Clinics
        11.9.4    Homecare Settings
        11.9.5    Others
    11.10    Global Psoriasis Treatment Market by Distribution Channel
        11.10.1    Market Overview
        11.10.2    Hospital Pharmacy
        11.10.3    Retail Pharmacy
        11.10.4    Online Pharmacy
        11.10.5    Others
    11.11    Global Psoriasis Treatment Market by Region
        11.11.1    Market Overview
        11.11.2    North America
        11.11.3    Europe 
        11.11.4    Asia Pacific
        11.11.5    Latin America
        11.11.6    Middle East and Africa
12    North America Psoriasis Treatment Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Psoriasis Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Psoriasis Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Psoriasis Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Psoriasis Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Pfizer Inc.
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Abbvie Inc.
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Novartis AG
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Amgen Inc.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Boehringer Ingelheim International GmbH.
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Merck & Co Inc.
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Sun Pharmaceutical Industries Ltd.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Teva Pharmaceuticals Industries Ltd. 
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    AstraZeneca
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Ampio Pharmaceuticals Inc.
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Eli Lilly and Company
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    Novartis International AG
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
    23.13    Sun Pharmaceuticals Industries Ltd.
        23.13.1    Financial Analysis
        23.13.2    Product Portfolio
        23.13.3    Demographic Reach and Achievements
        23.13.4    Mergers and Acquisitions
        23.13.5    Certifications
    23.14    Stiefel Laboratories
        23.14.1    Financial Analysis
        23.14.2    Product Portfolio
        23.14.3    Demographic Reach and Achievements
        23.14.4    Mergers and Acquisitions
        23.14.5    Certifications
    23.15    UCB S.A.
        23.15.1    Financial Analysis
        23.15.2    Product Portfolio
        23.15.3    Demographic Reach and Achievements
        23.15.4    Mergers and Acquisitions
        23.15.5    Certifications
    23.16    LEO Pharma
        23.16.1    Financial Analysis
        23.16.2    Product Portfolio
        23.16.3    Demographic Reach and Achievements
        23.16.4    Mergers and Acquisitions
        23.16.5    Certifications
    23.17    Cipla Inc.
        23.17.1    Financial Analysis
        23.17.2    Product Portfolio
        23.17.3    Demographic Reach and Achievements
        23.17.4    Mergers and Acquisitions
        23.17.5    Certifications
    23.18    Rowan Bioceuticals
        23.18.1    Financial Analysis
        23.18.2    Product Portfolio
        23.18.3    Demographic Reach and Achievements
        23.18.4    Mergers and Acquisitions
        23.18.5    Certifications
    23.19    Glenmark Pharmaceuticals
        23.19.1    Financial Analysis
        23.19.2    Product Portfolio
        23.19.3    Demographic Reach and Achievements
        23.19.4    Mergers and Acquisitions
        23.19.5    Certifications
    23.20    Win-Medicare Pvt. Ltd.
        23.20.1    Financial Analysis
        23.20.2    Product Portfolio
        23.20.3    Demographic Reach and Achievements
        23.20.4    Mergers and Acquisitions
        23.20.5    Certifications
    23.21    Sanofi S.A.
        23.21.1    Financial Analysis
        23.21.2    Product Portfolio
        23.21.3    Demographic Reach and Achievements
        23.21.4    Mergers and Acquisitions
        23.21.5    Certifications
24    Psoriasis Treatment Market- Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The psoriasis treatment market was valued at USD 28.54 billion in 2023.

The market is expected to grow at a CAGR of 9.2% from 2024 to 2032 to reach a value of USD 63.18 billion by 2032.

The increasing prevalence of psoriasis disease is augmenting the demand for an effective treatment, which is propelling the overall growth of the market.

The market is expected to be driven by the robust research and development (R&D) towards the development of an effective treatment of psoriasis. 

The major regional markets for psoriasis treatment are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

The major drug classes of psoriasis treatment are TNF inhibitors and interleukins, among others.

The different types of psoriasis treatment are plaque psoriasis, and psoriatic arthritis, among others.

The market, based on route of administration, can be segmented into oral, parenteral, and topical.

The significant distribution channels of psoriasis treatment are hospital pharmacies, retail pharmacies, and online pharmacies.

The major players in the industry are AbbVie Inc., Novartis AG, Johnson and Johnson Services, Inc., Pfizer Inc., and Merc and Co., Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER